RA CAPITAL MANAGEMENT, L.P. — Form 4 insider transactions

RA CAPITAL MANAGEMENT, L.P. — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-11-02 Buy Bambusa Therapeutics, Inc. 164,891 $16.00 $2,638,256 SEC filing
2026-11-02 Buy Bambusa Therapeutics, Inc. 2,335,109 $16.00 $37,361,744 SEC filing
2026-11-02 Conversion Bambusa Therapeutics, Inc. 1,331,080 — — SEC filing
2026-11-02 Conversion Bambusa Therapeutics, Inc. 3,144,858 — — SEC filing
2026-10-30 Buy Bambusa Therapeutics, Inc. 263,911 $14.92 $3,937,552 SEC filing
2026-10-30 Buy Bambusa Therapeutics, Inc. 189,909 $14.23 $2,702,405 SEC filing
2026-10-29 Sell LENZ Therapeutics, Inc. 107,170 $3.36 $360,091 SEC filing
2026-10-29 Sell LENZ Therapeutics, Inc. 451,998 $3.36 $1,518,713 SEC filing
2026-10-29 Sell LENZ Therapeutics, Inc. 2,159,516 $3.36 $7,255,974 SEC filing
2026-10-05 Award Wave Life Sciences, Inc. 10,700 — — SEC filing
2026-10-02 Opt exercise Vor Biopharma Inc. 500 $12.80 $6,400 SEC filing
2026-09-28 Opt exercise Climb Bio, Inc. 40,000 $1.29 $51,600 SEC filing
2026-09-28 Opt exercise Climb Bio, Inc. 10,000 $7.89 $78,900 SEC filing
2026-09-28 Opt exercise Climb Bio, Inc. 10,000 $3.00 $30,000 SEC filing
2026-09-28 Opt exercise Climb Bio, Inc. 10,000 $3.46 $34,600 SEC filing
2026-09-17 Sell Sionna Therapeutics, Inc. 33,800 $7.46 $252,148 SEC filing
2026-09-17 Sell Sionna Therapeutics, Inc. 3,415,011 $6.32 $21,582,870 SEC filing
2026-08-24 Opt exercise Vor Biopharma Inc. 1,500 $3.74 $5,604 SEC filing
2026-08-12 Sell Septerna, Inc. 746,500 $42.50 $31,726,250 SEC filing
2026-07-31 Buy Artiva Biotherapeutics, Inc. 24,944 $9.93 $247,694 SEC filing
2026-07-29 J Inhibikase Therapeutics, Inc. 18,030,000 — — SEC filing
2026-07-29 Buy Artiva Biotherapeutics, Inc. 20,824 $9.99 $208,032 SEC filing
2026-07-24 Buy Artiva Biotherapeutics, Inc. 41,319 $9.99 $412,777 SEC filing
2026-07-23 Buy Artiva Biotherapeutics, Inc. 59,880 $9.96 $596,405 SEC filing
2026-07-22 Buy Artiva Biotherapeutics, Inc. 84,124 $9.93 $835,351 SEC filing
2026-07-21 Buy Artiva Biotherapeutics, Inc. 120,582 $9.55 $1,151,558 SEC filing
2026-07-13 Buy Artiva Biotherapeutics, Inc. 6,522 $8.94 $58,307 SEC filing
2026-07-22 Buy Parabilis Medicines, Inc. 47,250 $29.77 $1,406,632 SEC filing
2026-07-21 Buy Parabilis Medicines, Inc. 37,723 $30.00 $1,131,690 SEC filing
2026-07-21 Buy Parabilis Medicines, Inc. 6,504 $29.17 $189,722 SEC filing
2026-07-21 Buy Parabilis Medicines, Inc. 21,696 $27.96 $606,620 SEC filing
2026-07-20 Buy Parabilis Medicines, Inc. 32,987 $27.72 $914,400 SEC filing
2026-07-20 Buy Parabilis Medicines, Inc. 98,433 $27.13 $2,670,487 SEC filing
2026-07-20 Award Freenome, Inc. 336,965 $10.00 $3,369,650 SEC filing
2026-07-20 Award Freenome, Inc. 4,918,411 $10.00 $49,184,110 SEC filing
2026-07-20 Award Freenome, Inc. 367,427 — — SEC filing
2026-07-20 Award Freenome, Inc. 908,103 — — SEC filing
2026-07-20 Award Freenome, Inc. 553,703 — — SEC filing
2026-07-20 Award Freenome, Inc. 970,950 — — SEC filing
2026-07-20 Award Freenome, Inc. 6,561,711 — — SEC filing
2026-07-16 Sell Vor Biopharma Inc. 213 $19.75 $4,207 SEC filing
2026-07-16 Opt exercise Vor Biopharma Inc. 2,100,000 $0.00 $4,200 SEC filing
2026-07-17 Buy Artiva Biotherapeutics, Inc. 7,882 $8.95 $70,544 SEC filing
2026-07-16 Buy Artiva Biotherapeutics, Inc. 152,472 $8.93 $1,361,575 SEC filing
2026-07-13 Buy Artiva Biotherapeutics, Inc. 6,552 $8.94 $58,575 SEC filing
2026-07-10 Buy Artiva Biotherapeutics, Inc. 15,102 $8.97 $135,465 SEC filing
2026-06-26 Buy Artiva Biotherapeutics, Inc. 1,876 $8.98 $16,846 SEC filing
2026-06-25 Buy Artiva Biotherapeutics, Inc. 31,000 $8.88 $275,280 SEC filing
2026-06-17 Sell Werewolf Therapeutics, Inc. 27,695 $0.35 $9,693 SEC filing
2026-06-17 Sell Werewolf Therapeutics, Inc. 389,216 $0.35 $136,226 SEC filing
2026-06-16 Buy Hemab Therapeutics Holdings, Inc. 61,523 $24.98 $1,536,845 SEC filing
2026-06-15 Buy Hemab Therapeutics Holdings, Inc. 6,146 $24.89 $152,974 SEC filing
2026-06-16 Sell Werewolf Therapeutics, Inc. 9,939 $0.37 $3,677 SEC filing
2026-06-16 Sell Werewolf Therapeutics, Inc. 139,686 $0.37 $51,684 SEC filing
2026-06-16 Buy Artiva Biotherapeutics, Inc. 124,893 $8.89 $1,110,299 SEC filing
2026-06-15 Sell Werewolf Therapeutics, Inc. 8,554 $0.39 $3,336 SEC filing
2026-06-15 Sell Werewolf Therapeutics, Inc. 120,216 $0.39 $46,884 SEC filing
2026-06-15 Buy Artiva Biotherapeutics, Inc. 15,414 $8.99 $138,572 SEC filing
2026-06-12 Sell Werewolf Therapeutics, Inc. 11,322 $0.40 $4,529 SEC filing
2026-06-12 Sell Werewolf Therapeutics, Inc. 159,119 $0.40 $63,648 SEC filing
2026-06-12 Buy Artiva Biotherapeutics, Inc. 391,019 $8.57 $3,351,033 SEC filing
2026-06-11 Buy Parabilis Medicines, Inc. 1,460,397 $20.00 $29,207,940 SEC filing
2026-06-11 Buy Parabilis Medicines, Inc. 19,728,353 $20.00 $394,567,060 SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 1,187,881 — — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 6,556,740 — — SEC filing
2026-06-11 Award Janux Therapeutics, Inc. 5,500 — — SEC filing
2026-06-11 Buy Artiva Biotherapeutics, Inc. 548,580 $7.91 $4,339,268 SEC filing
2026-06-11 Sell Werewolf Therapeutics, Inc. 17,437 $0.38 $6,626 SEC filing
2026-06-11 Sell Werewolf Therapeutics, Inc. 245,066 $0.38 $93,125 SEC filing
2026-06-10 Buy Artiva Biotherapeutics, Inc. 103 $7.00 $721 SEC filing
2026-06-10 Sell Werewolf Therapeutics, Inc. 3,051 $0.37 $1,129 SEC filing
2026-06-10 Sell Werewolf Therapeutics, Inc. 42,872 $0.37 $15,863 SEC filing
2026-06-09 Buy Artiva Biotherapeutics, Inc. 479,039 $6.91 $3,310,159 SEC filing
2026-06-09 Sell Werewolf Therapeutics, Inc. 24,565 $0.37 $9,089 SEC filing
2026-06-09 Sell Werewolf Therapeutics, Inc. 345,235 $0.37 $127,737 SEC filing
2026-06-03 Award Acumen Pharmaceuticals, Inc. 35,500 — — SEC filing
2026-05-20 Buy Hemab Therapeutics Holdings, Inc. 996 $24.94 $24,840 SEC filing
2026-05-19 Buy Hemab Therapeutics Holdings, Inc. 3,802 $24.97 $94,936 SEC filing
2026-05-18 Award Acrivon Therapeutics, Inc. 9,366 — — SEC filing
2026-05-12 Buy Hemab Therapeutics Holdings, Inc. 6,387 $24.90 $159,036 SEC filing
2026-05-11 Buy Artiva Biotherapeutics, Inc. 6,510,416 $11.52 $74,999,992 SEC filing
2026-05-12 Sell Werewolf Therapeutics, Inc. 6,719 $0.64 $4,300 SEC filing
2026-05-12 Sell Werewolf Therapeutics, Inc. 94,432 $0.64 $60,436 SEC filing
2026-05-11 Sell Werewolf Therapeutics, Inc. 5,812 $0.67 $3,894 SEC filing
2026-05-11 Sell Werewolf Therapeutics, Inc. 81,678 $0.67 $54,724 SEC filing
2026-05-08 Sell Werewolf Therapeutics, Inc. 25,012 $0.71 $17,759 SEC filing
2026-05-08 Sell Werewolf Therapeutics, Inc. 351,514 $0.71 $249,575 SEC filing
2026-05-11 Buy Hemab Therapeutics Holdings, Inc. 25,720 $25.00 $643,000 SEC filing
2026-05-11 Buy Hemab Therapeutics Holdings, Inc. 14,149 $24.47 $346,226 SEC filing
2026-05-08 Buy Hemab Therapeutics Holdings, Inc. 1,483 $24.98 $37,045 SEC filing
2026-05-07 Buy Hemab Therapeutics Holdings, Inc. 1,985 $24.95 $49,526 SEC filing
2026-05-07 Buy Hemab Therapeutics Holdings, Inc. 7,921 $24.34 $192,797 SEC filing
2026-05-06 Buy Hemab Therapeutics Holdings, Inc. 53,407 $24.83 $1,326,096 SEC filing
2026-05-06 Buy Hemab Therapeutics Holdings, Inc. 14,611 $23.77 $347,303 SEC filing
2026-05-05 Buy Hemab Therapeutics Holdings, Inc. 10,268 $25.00 $256,700 SEC filing
2026-05-05 Buy Hemab Therapeutics Holdings, Inc. 87,143 $24.59 $2,142,846 SEC filing
2026-05-04 Buy Hemab Therapeutics Holdings, Inc. 133,750 $18.00 $2,407,500 SEC filing
2026-05-04 Buy Hemab Therapeutics Holdings, Inc. 2,541,250 $18.00 $45,742,500 SEC filing
2026-05-04 Conversion Hemab Therapeutics Holdings, Inc. 221,188 — — SEC filing
2026-05-04 Conversion Hemab Therapeutics Holdings, Inc. 1,009,052 — — SEC filing
2026-05-04 Conversion Hemab Therapeutics Holdings, Inc. 3,607,846 — — SEC filing
2026-04-27 J Adicet Bio, Inc. 250,000 — — SEC filing
2026-04-27 J Prelude Therapeutics Inc 1,407,000 — — SEC filing
2026-04-22 Sell Vor Biopharma Inc. 165,150 $15.77 $2,604,416 SEC filing
2026-04-22 Award Acrivon Therapeutics, Inc. 3,888,888 $1.80 $6,999,998 SEC filing
2026-04-20 Sell Vor Biopharma Inc. 171,963 $15.77 $2,711,857 SEC filing
2026-04-17 Sell Vor Biopharma Inc. 458,411 $16.28 $7,462,931 SEC filing
2026-04-15 Sell Vor Biopharma Inc. 53,644 $16.01 $858,840 SEC filing
2026-04-14 Sell Vor Biopharma Inc. 153,735 $15.97 $2,455,148 SEC filing
2026-04-13 Sell Vor Biopharma Inc. 530,610 $16.15 $8,569,352 SEC filing
2026-02-20 Buy Adicet Bio, Inc. 74,751 $7.27 $543,440 SEC filing
2026-02-19 Buy Adicet Bio, Inc. 74,268 $7.21 $535,472 SEC filing
2026-02-18 Buy Adicet Bio, Inc. 74,577 $7.04 $525,022 SEC filing
2026-04-10 Sell Vor Biopharma Inc. 828 $15.75 $13,041 SEC filing
2026-04-09 Sell Vor Biopharma Inc. 135,201 $16.59 $2,242,985 SEC filing
2026-04-08 Sell Vor Biopharma Inc. 130,862 $16.91 $2,212,876 SEC filing
2026-04-08 Sell Vor Biopharma Inc. 353,242 $16.32 $5,764,909 SEC filing
2026-04-06 Sell Vor Biopharma Inc. 6,775 $18.50 $125,338 SEC filing
2026-04-06 Sell Vor Biopharma Inc. 44,728 $17.31 $774,242 SEC filing
2026-04-06 Sell Vor Biopharma Inc. 537,754 $16.51 $8,878,319 SEC filing
2026-04-02 Sell Vor Biopharma Inc. 1,525 $19.06 $29,066 SEC filing
2026-04-02 Sell Vor Biopharma Inc. 258,475 $18.23 $4,711,999 SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →